Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Arrowhead Pharmaceuticals to Webcast Fiscal 2021 First Quarter Results

Abstract:
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on February 4, 2021, at 4:30 p.m. EST to discuss its financial results for the fiscal first quarter ended December 31, 2020.

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 First Quarter Results

Pasadena. CA | Posted on January 20th, 2021

Conference Call and Webcast Details

Investors may access a live audio webcast on the Company's website at http://ir.arrowheadpharma.com/events.cfm . For analysts that wish to participate in the conference call, please dial 855-215-6159 or 315-625-6887 and provide Conference ID 1307499.

A replay of the webcast will be available on the company’s website approximately two hours after the conclusion of the call and will remain available for 90 days. An audio replay will also be available approximately two hours after the conclusion of the call and will be available for 3 days. To access the audio replay, dial 855-859-2056 or 404-537-3406 and provide Conference ID 1307499.

####

About Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing.

For more information, please visit www.arrowheadpharma.com, or follow us on Twitter @ArrowheadPharma. To be added to the Company's email list and receive news directly, please visit http://ir.arrowheadpharma.com/email-alerts .

Safe Harbor Statement under the Private Securities Litigation Reform Act:

This news release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the safety and efficacy of our product candidates, the duration and impact of regulatory delays in our clinical programs, our ability to finance our operations, the likelihood and timing of the receipt of future milestone and licensing fees, the future success of our scientific studies, our ability to successfully develop and commercialize drug candidates, the timing for starting and completing clinical trials, rapid technological change in our markets, and the enforcement of our intellectual property rights. Our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q discuss some of the important risk factors that may affect our business, results of operations and financial condition. We assume no obligation to update or revise forward-looking statements to reflect new events or circumstances.

For more information, please click here

Contacts:
Arrowhead Pharmaceuticals, Inc.
Vince Anzalone, CFA
626-304-3400


Investors:
LifeSci Advisors, LLC
Brian Ritchie
212-915-2578

www.lifesciadvisors.com

Media:
LifeSci Communications, LLC
Josephine Belluardo, Ph.D.
646-751-4361

www.lifescicommunications.com

Copyright © Arrowhead Pharmaceuticals, Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Princeton-led team discovers unexpected quantum behavior in kagome lattice:Experiments suggest evidence for novel patterns of electronic charge distribution in a kagome material whose handedness can be manipulated with a magnetic field June 18th, 2021

Atomic-scale tailoring of graphene approaches macroscopic world June 18th, 2021

Compact quantum computer for server centers: Researchers build smallest quantum computer yet based on industry standards June 18th, 2021

Changing a 2D material's symmetry can unlock its promise: Jian Shi Research Group engineers material into promising optoelectronic June 18th, 2021

Possible Futures

AI app could help diagnose HIV more accurately: Pioneering technology developed by UCL (University College London) and Africa Health Research Institute (AHRI) researchers could transform the ability to accurately interpret HIV test results, particularly in low- and middle-income June 18th, 2021

Atomic-scale tailoring of graphene approaches macroscopic world June 18th, 2021

Compact quantum computer for server centers: Researchers build smallest quantum computer yet based on industry standards June 18th, 2021

Changing a 2D material's symmetry can unlock its promise: Jian Shi Research Group engineers material into promising optoelectronic June 18th, 2021

Nanomedicine

AI app could help diagnose HIV more accurately: Pioneering technology developed by UCL (University College London) and Africa Health Research Institute (AHRI) researchers could transform the ability to accurately interpret HIV test results, particularly in low- and middle-income June 18th, 2021

'Nanodecoy' therapy binds and neutralizes SARS-CoV-2 virus June 18th, 2021

Turning the heat on: A flexible device for localized heat treatment of living tissues June 11th, 2021

Arrowhead Pharmaceuticals to Participate in Upcoming Conferences June 2nd, 2021

Announcements

Proliferation of electric vehicles based on high-performance, low-cost sodium-ion battery:A large-capacity anode material is developed for sodium-ion batteries by using low-cost silicone-based oil. This process, if commercialized, is expected to significantly reduce manufacturing June 18th, 2021

AI app could help diagnose HIV more accurately: Pioneering technology developed by UCL (University College London) and Africa Health Research Institute (AHRI) researchers could transform the ability to accurately interpret HIV test results, particularly in low- and middle-income June 18th, 2021

Compact quantum computer for server centers: Researchers build smallest quantum computer yet based on industry standards June 18th, 2021

Changing a 2D material's symmetry can unlock its promise: Jian Shi Research Group engineers material into promising optoelectronic June 18th, 2021

Financial Reports

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor February 22nd, 2021

Events/Classes

NASA Chief Scientist Dr. Jim Green to Appear at the Online NSS International Space Development Conference 2021: This Year's Virtual Conference Streams Free to ALL June 11th, 2021

Arrowhead Pharmaceuticals to Participate in Upcoming Conferences June 2nd, 2021

Arrowhead Pharmaceuticals to Participate in Upcoming Conferences June 2nd, 2021

CEA-Leti Introduces Plastic mmWave System for Applications Requiring Ultra-Low Latency and Ultra-High-Speed Connectivity: Low-Cost Gb/s Connectivity Overcomes Limits of Copper Wire and Optical Fiber For Automotive, Aeronautics, Telecom, Industry 4.0 and Healthcare Uses May 28th, 2021

Nanobiotechnology

AI app could help diagnose HIV more accurately: Pioneering technology developed by UCL (University College London) and Africa Health Research Institute (AHRI) researchers could transform the ability to accurately interpret HIV test results, particularly in low- and middle-income June 18th, 2021

'Nanodecoy' therapy binds and neutralizes SARS-CoV-2 virus June 18th, 2021

Turning the heat on: A flexible device for localized heat treatment of living tissues June 11th, 2021

Arrowhead Pharmaceuticals to Participate in Upcoming Conferences June 2nd, 2021

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project